1. Institute of Experimental Hematology and
2. Research Group Reprogramming and Gene Therapy, REBIRTH Cluster-of Excellence, Hannover Medical School, Hannover, Germany;
3. Institute for Experimental Infection Research, TWINCORE, Centre for Experimental and Clinical Infection Research, Hannover, Germany;
4. Young Research Group Translational Hematology of Congenital Diseases, REBIRTH Cluster-of Excellence,
5. Institute of Immunology,
6. Institute for Pathology, and
7. Institute of Medical Microbiology and Hospital Epidemiology, Hannover Medical School, Hannover, Germany;
8. Department of Pathology and
9. Institute for Microbiology, Department of Infectious Diseases, University of Veterinary Medicine Hannover, Hannover, Germany;
10. San Raffaele Telethon Institute for Gene Therapy, Scientific Institute Hospital San Raffaele, Milan, Italy;
11. Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France;
12. Paris Descartes University, Imagine Institute, Paris, France;
13. St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY;
14. Howard Hughes Medical Institute, New York, NY;
15. Pediatric Hematology-Immunology Unit and
16. Center for the Study of Primary Immunodeficiencies, Assistance Publique–Hôpitaux de Paris, Necker Hospital for Sick Children, Paris, France; and
17. Division of Hematology/Oncology, Boston Children’s Hospital, Boston, MA